IP Library Granted Patent US 11,466,296
Granted Patent B2
US 11,466,296 · App. 16/934,359 · Granted Oct 11, 2022

Genetically-modified bacteria for conversion of organic compounds to butanol and methods of use

Inventors: Adam M. Guss (Knoxville, TN); Lauren A. Riley (Knoxville, TN)
Assignee: UT-Battelle, LLC
C12P7/16C12N9/001C12N9/0008C12N1/205C12R2001/01C12Y102/01057C12Y103/01086
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,466,296
App. No.
16/934,359
Granted
Oct 11, 2022
Kind
B2
Abstract

This disclosure provides a genetically-modified bacterium from the genus Megasphaera that comprises an exogenous nucleic acid encoding a bifunctional aldehyde/alcohol dehydrogenase that produces butanol as the final product. The disclosure further provides methods for producing butanol using such genetically-modified bacterium.

Claims (9)

1. A genetically-modified bacterium of Megasphaera elsdenii , comprising a sole exogenous nucleic acid of a carbon chain elongation pathway encoding a bifunctional aldehyde/alcohol dehydrogenase, wherein the bifunctional aldehyde/alcohol dehydrogenase produces butanol as a final product and comprises an amino acid sequence with at least 90% identity to SEQ ID NO: 1, and wherein the genetically-modified bacterium has increased butanol production using lactate as the carbon source compared to a wild type Megasphaera elsdenii.

2. The genetically-modified bacterium of claim 1 , wherein the bifunctional aldehyde/alcohol dehydrogenase is an enzyme from a bacterial species that belongs to the genus Clostridium.

3. The genetically-modified bacterium of claim 1 , wherein the exogenous nucleic acid sequence is codon optimized for Megasphaera elsdenii.

4. The genetically-modified bacterium of claim 1 , wherein the genetically-modified bacterium is an M. elsdenii strain designated as ATCC 25940.

5. A method for converting an organic compound to butanol, the method comprising inoculating a medium comprising said organic compound with the genetically-modified bacterium of claim 1 , thereby converting said organic compound to butanol, wherein the organic compound is lactate.

6. The method of claim 5 , wherein the bifunctional aldehyde/alcohol dehydrogenase is an enzyme from a bacterial species from the genus Clostridium.

7. The method of claim 5 , wherein the exogenous nucleic acid sequence is codon optimized for Megasphaera elsdenii.

8. The method of claim 3 , wherein the lactate is a product of bacterial fermentation, a product of fungal fermentation, a product of chemical synthesis from acetaldehyde, or a composition comprising purified lactate.

9. The method of claim 5 , wherein the genetically-modified bacterium is an M. elsdenii strain designated as ATCC 25940.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2022
From: GUSS, ADAM M.
To: UT-BATTELLE, LLC
Reel/Frame 060019/0975 →
CONFIRMATORY LICENSE Recorded Nov 23, 2020
From: UT-BATTELLE, LLC
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 054499/0865 →
Continuity (2)
Provisional Application 62876886 · Jul 22, 2019
Related Publication 20210024965A1 · Jan 28, 2021
Cited By (1)
US 12,325,859